Balance Sheet
Cash Flow Statement
AmortizationAmortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioLineRx (BLRX) Non-cash Items (2023 - 2025)

Historic Non-cash Items for BioLineRx (BLRX) over the last 3 years, with Q3 2025 value amounting to $228000.0.

  • BioLineRx's Non-cash Items rose 10569.57% to $228000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.5 million, marking a year-over-year decrease of 147.77%. This contributed to the annual value of -$34.7 million for FY2024, which is 19117.51% down from last year.
  • BioLineRx's Non-cash Items amounted to $228000.0 in Q3 2025, which was up 10569.57% from $2.4 million recorded in Q2 2025.
  • BioLineRx's 5-year Non-cash Items high stood at $18.9 million for Q4 2023, and its period low was -$13.4 million during Q1 2024.
  • For the 3-year period, BioLineRx's Non-cash Items averaged around -$157272.7, with its median value being $228000.0 (2025).
  • In the last 5 years, BioLineRx's Non-cash Items crashed by 42351.66% in 2024 and then skyrocketed by 12036.74% in 2025.
  • Over the past 3 years, BioLineRx's Non-cash Items (Quarter) stood at $18.9 million in 2023, then crashed by 128.73% to -$5.4 million in 2024, then soared by 104.2% to $228000.0 in 2025.
  • Its Non-cash Items stands at $228000.0 for Q3 2025, versus $2.4 million for Q2 2025 and -$7.7 million for Q1 2025.